Department of Ophthalmology, Fourth Affiliated Hospital of Kunming Medical University (the Second People's Hospital of Yunnan Province); Yunnan Eye Institute; Key Laboratory of Yunnan Province for the Prevention and Treatment of ophthalmology (2017DG008); Provincial Innovation Team for Cataract and Ocular Fundus Disease, The Second People's Hospital of Yunnan Province (2017HC010); Expert Workstation of Yao Ke (2017IC064), Kunming 650021, China.
Yan'An Hospital of Kunming City, Kunming 650051, China.
Int J Med Sci. 2019 Jan 1;16(2):198-202. doi: 10.7150/ijms.30118. eCollection 2019.
Myopia is an important public health problem due to its prevalence and significant public health cost. Elevating levels of myopia increase the risk of vision impairment, and therefore, high myopia has become one of the main causes of untreatable vision loss throughout the world due to its irreversible complications. At present, many options for slowing progression of myopia have already been proposed and evaluated such as progressive addition of executive bifocal spectacle lenses, peripheral defocusing lenses, overnight orthokeratology, pharmacological agents such as atropine eye drops, and multifocal soft contact lenses (MFSCLs). Use of MFSCLs has especially increased in recent years due to the growing demand to slow myopia progression during patient's adolescent growth period to avoid pathological myopia in adulthood. Compared with the other traditional methods of controlling myopia, MFSCLs allow myopic patients to better maintain their clear visual quality and slow myopia progression. In this manuscript, we aim to review the basics of myopia, recent advances in contact lenses to control myopia with emphasis on MFSCLs, define the elements for proper MFSCL fittings (such as pupil size, aberrations, accommodation and centering), discuss the potential rebound effect after discontinuation of contact lenses, and future directions for improvements of contact lenses for the control of myopia.
近视是一个重要的公共卫生问题,因为它的发病率高,且会产生重大的公共卫生成本。近视程度的加深增加了视力受损的风险,因此,高度近视已成为全球不可治疗的视力丧失的主要原因之一,因为它的并发症是不可逆转的。目前,已经提出并评估了许多减缓近视进展的选择,例如渐进式添加执行双焦点眼镜、周边离焦镜片、夜间角膜塑形术、阿托品滴眼液等药物,以及多焦点软性隐形眼镜 (MFSCL)。近年来,由于在青少年生长期间减缓近视进展以避免成年后发生病理性近视的需求不断增长,MFSCL 的使用尤其增加。与控制近视的其他传统方法相比,MFSCL 允许近视患者更好地保持清晰的视觉质量并减缓近视进展。在本文中,我们旨在回顾近视的基础知识,以及近年来控制近视的隐形眼镜的最新进展,重点介绍 MFSCL,定义适当的 MFSCL 适配要素(如瞳孔大小、像差、调节和中心定位),讨论停止使用隐形眼镜后的潜在反弹效应,以及控制近视的隐形眼镜改进的未来方向。